ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

FDBK Feedback Plc

80.00
-2.50 (-3.03%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.50 -3.03% 80.00 75.00 85.00 82.50 80.00 82.50 12,708 10:27:36
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -3.66 10.67M
Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 82.50p. Over the last year, Feedback shares have traded in a share price range of 58.00p to 150.00p.

Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £10.67 million. Feedback has a price to earnings ratio (PE ratio) of -3.66.

Feedback Share Discussion Threads

Showing 12926 to 12944 of 14825 messages
Chat Pages: Latest  521  520  519  518  517  516  515  514  513  512  511  510  Older
DateSubjectAuthorDiscuss
22/1/2022
00:54
“A few weeks into the pandemic the Government announced that the terms of the UK 2018 Data Protection Act (which incorporates the GDPR) would be suspended in relation to health care for the duration of the crisis, and that healthcare professionals should feel free to continue using non-compliant consumer messaging platforms to communicate without fear of reprimand or censure.”
petekand
22/1/2022
00:48
All that stands but for Bleepa it has to be seen as secure and compliant regardless of the current temporary situation and they should find themselves miles ahead of the game once rules are reversed. Imagine a bank saying sod GDPR it’s COVID.
petekand
21/1/2022
23:48
Why? Life's too short.

What was all this about then, Pete?:-

ged5
20/1/2022
22:12
The funny thing is we shareholders don’t even have anything concrete to ramp about but Tom reckons we are the most exciting medical stock on the Aim.
Perhaps this will prove up some day but right now space watching is extremely tedious.

petekand
20/1/2022
19:18
Good luck with your short kaka. If your feelings are correct you will profit well.
I fail to find any rampers on this thread, you however, may qualify as a deramper.

ducatiman
20/1/2022
18:55
Question to Rampers How many keep the lights on deeply discounted placings since listing.
kaka47
20/1/2022
18:53
Eye popping 22mil Mcap Unbelievably overpriced glorified messaging stock on AIM with revenue of just 0.29k Fully expecting Mcap to drop big time
kaka47
19/1/2022
22:39
He's gone twittering.
lr2
19/1/2022
22:14
Where’s Tom exactly gone with the £11.2 million? I would really like to know.
petekand
19/1/2022
20:30
A competitor bites the dust.Hospify platform to shut down following suspension of Data Protection Acthttps://www.digitalhealth.net/2022/01/hospify-platform-shut-down-data-protection-act/
ragnarr
19/1/2022
19:13
NHS bosses in Lincolnshire want to build new Community Diagnostic Centreshttps://thelincolnite.co.uk/2022/01/community-diagnostic-centres-planned-to-ease-pressure-on-nhs-hospitals/
ragnarr
18/1/2022
19:16
“Community diagnostic centres like the one I visited in Finchley today allow for checks closer to your home and quicker diagnosis and treatment. They will be vital in cutting NHS waiting lists

We’re investing £2.3 billion into opening 100 centres like this by 2025.”
Boris.

ducatiman
18/1/2022
18:09
Beyond 100 Playbook

Download can be found here.



Bleepa is on page 33.

Bleepa

Company Profile:
Bleepa is a revolutionary medical imaging communications app, providing an easy-to-use, high-quality tool to enable remote and secure communications between frontline clinicians and teams. It is a safe, secure CE-accredited platform accessible from any internet-connected device, enabling control of patient cases when on the go. Bleepa is the app that connects medical professionals safely and securely to view, share and annotate clinical images.

Keywords:
Medical imaging, remote working, mobile access, instant messaging.

Current operating countries:
UK & India

lr2
17/1/2022
21:25
Cant be a bad thing for Feedback.Joint Statement of the 15th Meeting of the India-UK Joint Economic and Trade Committee..https://www.gov.uk/government/news/india-uk-joint-statement-on-the-jetco12. Both sides recognised the growing importance and high potential of cooperation in digital trade and tech and encouraged swift progress in concluding a Joint Declaration of Intent (JDI) between the Department for Digital, Culture, Media and Sports (DCMS) and the Ministry of Electronics and Information Technology. Establishing a Joint Working Group under the JDI and facilitating a ministerial level dialogue will deepen UK-India cooperation on digital and tech, including supporting collaboration on emerging tech.
ragnarr
17/1/2022
19:13
More chunks of stock changing hands today! Somebody is keen. I wonder if we will see a holding RNS soon?
ducatiman
17/1/2022
15:06
Ragnarr

Thanks for that. Hopefully signing up a contract for Bleepa won’t be such a big deal for those trusts as an entire inaging system.

yump
17/1/2022
13:53
Says the poster that stated this morning DVRG is going nowhere - errr up 17 percent doh!
ragnarr
16/1/2022
23:15
Bleeps is a glorified messaging app. Burning through deeply discounted placing cash, soon company would be bringing out the deeply discounted beginning bowl again. Can someone tell me how many deeply discounted placings sofar and how many millions have been wasted to generate just 0.29 revenue. At 22mil Mcap seriously overpriced fully expecting the share price to drift below 0.50 and then lower and lower
kaka47
16/1/2022
15:40
Thanks again Ragnarr. The relevant text was a little difficult to access on the laptop so I've put it in chronological order.

Shows these contacts take time.

So if Bleepa and Sectra are working well together in two areas, then what's the potential for Bleepa moving to other areas where Sectra is used. They're in many places including the US.




04-06-2021- RIS BC approved. Timelines aggressive for migration so could impact wider project. PACS BC - BAFO completed by 2 final vendors. Clinical consensus over preferred vendor has been reached and formal BC being written. Approval board within Trust has identified. VNA - no update. ongoing issues with delete API. Other trusts have started migration

30-06-2021 - RIS timeline likely to slip a little. VNA - now have come up with an archive only solution which is the best least risk option for the consortium given the delete API issue cannot be sorted. PACS BC being finalized and need approval at august board. rationale/scope/general risks presented to diagnostic elective care
board 30-06-21. Only queries around downtime - not possible to answer currently.

20-07-2021 - PACS BC discussed at EMT/HMT - supported. Awaiting Trust Board approval 5th August. Risk update paper submitted for F&P on the 20th July.

24-08-2021 VNA go live - some trust have migrated. Archive only solution. Hyland and Sectra need to devise migration process. RIS start date still not confirmed. PACS BC still needs approval at UHS.

22-09-2021 - Nearly at the end of the contract negotiations with Sectra. Meeting with Phillips on Monday about exit strategy and their costs. VNA - proposed solution which comes under CCN - costs to be worked through. New RIS projected go live -November.

18-10-2021 - Capsticks completed legal review and several meetings to go over findings. Trusts being asked to raise POs for Sectra contract. VNA - still problematic in terms of final solution and costs not being set completely. Ongoing high level meetings in regard this. RIS - issues with Go live date keep moving. Updated RFC sent to trusts to complete tests to test environment prior to doing the data replication from LIVE.

19-11-2021 - VNA - hyland sent dispute letters re non-payment of invoices and said all support would stop from 17th. Legal advice sought from Shoe lane solicitor. Reply letters devised and sent on the 17th. PACS and RIS all fine - finalizing
PID for PACS for contract and RIS - minor changes to test environment next week - both moving forward. Trust project teams being devised for PACS go live.

23-12-2021 - PACS project team being worked out with dept and working through support required. RIS Test environment changes still not fully working at QVH. Issues being worked on with a planned change over in the live environment for 12h
Feb 2022. VNA - Hyland, legal advice with SROs approving letter of termination with Hyland. This needs to be worked through. have copied status update into documents re this.

ged5
Chat Pages: Latest  521  520  519  518  517  516  515  514  513  512  511  510  Older

Your Recent History

Delayed Upgrade Clock